Byrne Asset Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$13K Buy
+300
New +$13.9K 0.01% 423
2026
Q2
– Sell
-82
Closed -$5.15K – 597
2026
Q1
$5.15K Buy
82
+72
+720% +$5.76K ﹤0.01% 482
2025
Q4
$954 Sell
10
-10
-50% -$980 ﹤0.01% 533
2025
Q3
$1.95K Buy
+20
New +$2.07K ﹤0.01% 519

Other funds holding BSX

Byrne Asset Management's BSX Position: Q3 2026 in Review

Byrne Asset Management opened a new position in Boston Scientific (BSX) in Q3 2026: 300 shares worth $13K. The stake represents 0.01% of the portfolio and ranks #423 among its holdings. This is a return to the name: Byrne Asset Management previously reported a position in BSX as recently as Q1 2026.

Byrne Asset Management first reported a position in BSX in Q3 2025 and has held it in 4 quarters since. 43 funds tracked by Wall St. Rank hold BSX as of Q3 2026.

  • Byrne Asset Management held 300 shares of Boston Scientific worth $13K as of Q3 2026.
  • Boston Scientific was a new Byrne Asset Management position in Q3 2026.
  • Boston Scientific made up 0.01% of Byrne Asset Management's portfolio in Q3 2026, its #423 holding.
  • Byrne Asset Management first reported a position in Boston Scientific in Q3 2025 and has held it in 4 quarters since.
  • 43 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2026.

Based on Byrne Asset Management's 13F filing for Q3 2026, filed 6 Oct 2026.